UNISON HEALTHCARE CORP
NT 10-Q, 1998-05-18
NURSING & PERSONAL CARE FACILITIES
Previous: MMCA AUTO OWNER TRUST 1995-1, 8-K, 1998-05-18
Next: VAN DE KAMPS INC, 8-K, 1998-05-18



                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                                Commission File Number: 0-27374
                                                                       ---------
(Check One):  [ ] Form 10-K and Form 10-KSB   [X] Form 10-Q and Form 10-QSB
              [ ] Form 20-F  [ ] Form 11-K    [ ] Form N-SAR

For Period Ended: March 31, 1998
                 ------------------------
[ ] Transition Report on Form 10-K    [ ] Transition Report on Form 20-F 
[ ] Transition Report on Form 11-K    [ ] Transition Report on Form 10-Q 
[ ] Transition Report on Form N-SAR

For the Transition Period Ended:

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

                          Unison HealthCare Corporation
                          -----------------------------
                             Full Name of Registrant

                                   
                            -------------------------
                            Former Name if Applicable

                         8800 N. Gainey Center Dr., #245
            ---------------------------------------------------------
            Address of Principal Executive Office (Street and Number)

                            Scottsdale, Arizona 85258
                            -------------------------
                            City, State and Zip Code

PART II - RULES 12b-25(b) and (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[ ]  (a) The reasons  described  in  reasonable  detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

[ ]  (b) The subject annual report,  semi-annual  report,  transition  report on
     Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion  thereof,  will be filed
     on or before the fifteenth  calendar day following the prescribed due date;
     or the  subject  quarterly  report of  transition  report on Form 10-Q,  or
     portion thereof will be filed on or before the fifth calendar day following
     the prescribed due date; and

[ ]  (c) The accountant's  statement or other exhibit required by rule 12b-25(c)
     has been attached if applicable.
<PAGE>
PART III - NARRATIVE

State below in reasonable  detail the reasons why the Form 10-K and Form 10-KSB,
11-K, 20-F, 10-Q and Form 10-QSB,  N-SAR, or other transition  report or portion
thereof, could not be filed within the prescribed period.

Unison  HealthCare  Corporation  (the  "Company")  previously  reported  that it
continues to experience financial  difficulties and has been unsuccessful in its
efforts  to reduce  its cost of  capital  and  operating  expenses  and  provide
liquidity.  The Company's cashflow shortfalls persist and management is focusing
its efforts on improving operations and completing a financial  restructuring of
the Company. These events have delayed and are expected to continue to delay the
preparation  of the  Company's  Annual  Report on Form  10-K for the year  ended
December 31, 1997 and the Company's  quarterly report on Form 10-Q for the three
months ended March 31, 1998.

PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification

           Nir E. Margalit         (602)                 423-1954
           -------------------------------------------------------------
           (Name)              (Area Code)            (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months (or for such shorter period that the
     registrant was required to file such reports), been filed. If answer is no,
     identify report(s).                                         [ ] YES [X] NO

     Annual Report on Form 10-K for the year ended December 31, 1997

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings statement to be included in the subject report or portion thereof?
                                                                  [X] YES [ ] NO

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

The Company  recorded a pretax loss of $5.0  million for the three  months ended
March 31,  1998  compared  to a pretax  loss of $6.1  million  in the 1997 first
quarter.  Revenues  decreased  1.9%  to  $54.7  million  due  primarily  to  the
disposition  of three  nursing  facilities  on March 1, 1997.  Wages and related
expenses  decreased 5.4% to $28.0 million.  Other operating  expenses  decreased
7.0% to $19.5 million.  Interest expense increased from $4.7 million in the 1997
first  quarter to $5.8  million in the 1998 period due  primarily to the sale of
$20 million of Senior Notes due 1999 on December 1, 1997,  interest penalties on
its $100 million of Senior Notes due 2006, and increases in other borrowings.

                          Unison HealthCare Corporation
                  --------------------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date: May 18, 1998               By:  /s/ MICHAEL A. JEFFRIES
                                      ---------------------------------
                                 Name:  Michael A. Jeffries
                                 Title: President and Chief Executive Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission